Latest Posts
Living day by day
The Multiple Sclerosis Society of Canada’s Vitamin D recommendations provide general information on vitamin D, where you can get vitamin D, how the…
Overcoming loss and MS through fitness
Ten years ago, Emily Huner was diagnosed with multiple sclerosis. It was not part of her plan. A self-described active and type-A individual,…
Use your voice to help improve #LifeWithMS
Canada has one of the highest rates of multiple sclerosis (MS) in the world. Every day an average of 11 Canadians are diagnosed…
ECTRIMS 2018: Updates on Progressive MS
Which subgroups of progressive MS should be treated? Dr. Xavier Montalban, professor at the University of Toronto, presented an overview of treatments in…
ECTRIMS 2018: Catching up with the MS-Society funded collaborative team that is working to improve cognition in people with progressive MS
The Multiple Sclerosis Society of Canada announced last month a $5 million grant in support of the first, international, multicenter clinical trial to investigate cognitive…
ECTRIMS 2018: Risk Factors for multiple sclerosis (MS)
Overview of the growing list of potential risk factors for MS Dr. Ali Manouchehrinia, Assistant Professor at the Karolinska Institutet, presented an overview…
Guten Tag! The research team will be live at the world’s largest conference in Berlin, Germany next week
The MS Society of Canada’s research team is preparing to fly over the Atlantic to the exciting city of Berlin, Germany to attend…
A mother-daughter bond stronger than MS
Guest post by Alli Leithoff, MS Bike ambassador Growing up, it is normal for every girl to argue with their mom, but not…
Improving cognitive function in MS: A researcher looking to make a difference for people diagnosed with progressive MS
Cognitive impairment, a research priority for the MS Society of Canada, affects a significant proportion of people living with MS. Multiple sclerosis (MS)…
What is MS?
Canada has one of the highest rates of multiple sclerosis (MS) in the world, with an estimated 77,000 Canadians living with the disease. While it is most often diagnosed in young adults aged 20 to 49, younger children and older adults are also diagnosed with the disease.